Cargando…
Risk of Infections With Long-Term Left Ventricular Assist Device Support
The average life expectancy post-left ventricular assist device (LVAD) implantation has significantly increased in recent years. Impaired cellular immunity post-LVAD implantation has been suggested. It is not clear if a prolonged duration of LVAD support will lead to an increase in infections and po...
Autores principales: | Karnatak, Rajendra, Sandkovsky, Uriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402930/ https://www.ncbi.nlm.nih.gov/pubmed/37546149 http://dx.doi.org/10.7759/cureus.41412 |
Ejemplares similares
-
Long-Term Withdrawal of Anticoagulation and Antiplatelet Therapy in a HeartMate 3 Left Ventricular Assist Device
por: Menchaca, Kristina, et al.
Publicado: (2022) -
Hemodynamic Assessment of Dual Obstructive Left Ventricular Assist Device Lesions
por: Kassi, Mahwash, et al.
Publicado: (2021) -
Trends, Outcomes, and Predictors of Sepsis and Severe Sepsis in Patients with Left Ventricular Assist Devices
por: Gonuguntla, Karthik, et al.
Publicado: (2020) -
Utility of Fiberoptic Endoscopic Evaluation of Swallowing After Left Ventricular Assist Device Implantation
por: Sharaf, Omar M, et al.
Publicado: (2023) -
Intracranial Mycotic Aneurysm in a Left Ventricular Assist Device Patient: A Complication to Avoid
por: Pachariyanon, Pavida, et al.
Publicado: (2020)